1. Home
  2. BURL vs GMAB Comparison

BURL vs GMAB Comparison

Compare BURL & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BURL

Burlington Stores Inc.

HOLD

Current Price

$250.68

Market Cap

16.8B

ML Signal

HOLD

Logo Genmab A/S ADS

GMAB

Genmab A/S ADS

HOLD

Current Price

$31.70

Market Cap

17.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BURL
GMAB
Founded
1972
1999
Country
United States
Denmark
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8B
17.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BURL
GMAB
Price
$250.68
$31.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
6
Target Price
$336.57
$40.40
AVG Volume (30 Days)
1.3M
1.7M
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
19.59
132.41
EPS
8.72
25.10
Revenue
$11,187,977,000.00
$3,845,670,022.00
Revenue This Year
$9.78
$24.92
Revenue Next Year
$9.68
$15.97
P/E Ratio
$28.55
$1.26
Revenue Growth
6.81
29.57
52 Week Low
$212.92
$17.24
52 Week High
$309.00
$33.65

Technical Indicators

Market Signals
Indicator
BURL
GMAB
Relative Strength Index (RSI) 40.27 60.90
Support Level $240.49 $31.32
Resistance Level $265.46 $32.48
Average True Range (ATR) 10.29 0.61
MACD -4.27 0.15
Stochastic Oscillator 16.11 72.06

Price Performance

Historical Comparison
BURL
GMAB

About BURL Burlington Stores Inc.

Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.

About GMAB Genmab A/S ADS

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.

Share on Social Networks: